October 9, 2014 — Earlier this month Hologic President and CEO Stephen MacMillan presided over the NASDAQ stock market opening bell ceremony on Oct. 1, the first day of Breast Cancer Awareness Month.
In his remarks, MacMillan discussed the company’s campaign focused on the important benefits of Hologic’s 3-D mammography technology. This is the ninth consecutive year that Hologic has been invited to participate in the NASDAQ opening bell ceremony on the first business day in October.
“It is an honor to host the NASDAQ opening bell ceremony on the first day of Breast Cancer Awareness Month,” said MacMillan. “We are committed to developing technologies that detect diseases earlier and improve patient outcomes. Our 3D mammography technology addresses the limitations of traditional mammography – the over-diagnosis of noninvasive cancers and unnecessary recalls for additional testing – with the demonstrated ability to increase the detection rate of invasive cancers. It is the first and only 3-D system that is clinically proven to be superior to traditional 2-D mammography.”
Hologic was the first company to receive U.S. Food and Drug Administration (FDA) approval for its 3-D mammography system. This technology was approved for breast cancer screening and diagnosis in the United States in February 2011 and in countries recognizing CE mark since 2008. Hologic offers a comprehensive 3-D platform, including low-dose 3-D mammography, as well as the first FDA-approved 3-D guided breast biopsy system.
For more information: www.hologic.com
February 18, 2026 
